Introduction
============

The ovary is one of the most radiosensitive organs and its function is affected even with low doses of radiation. Radiation treatment changes the appearance of normal ovarian tissue and ovarian tumors and causes ovarian failure [@B1]-[@B3]. Typical changes in the normal ovary include destruction of primordial follicles, stromal fibrosis, and sclerosis of blood vessels. Radiation changes in benign and malignant ovarian tumors may create a histologic pattern that is difficult to interpret. To our knowledge, there are no previous reports of radiation-related changes in ovarian sex cord-stromal tumors. We present an unusual stromal neoplasm with features of sclerosing stromal tumor and fibrothecoma [@B1], [@B4], [@B5] in a patient previously treated with radiation for carcinoma of the cervix. The differential diagnosis and the use of immunohistochemical stains are discussed.

Case Report
===========

A 38 year-old woman gravida 1 and para 0 presented with a pelvic mass discovered during the work-up following treatment for cervical cancer. Her past medical history included Stage IIB invasive squamous cell carcinoma of the cervix, treated with cone biopsy and brachytherapy. On an ultrasound, a large heterogeneous mass on the right side of the uterus was identified. A positron-emission tomography/computed tomography scan showed a heterogeneously enhancing tumor arising from the right adnexa/broad ligament, with borderline FDG activity consistent with benign characteristics. Magnetic resonance imaging revealed a 10.1 x 10.1 x 10.2 cm heterogeneously enhancing right solid ovarian mass. With preoperative diagnosis of ovarian tumor, the patient underwent bilateral salpingo-oophorectomy. The right tubo-ovarian complex weighed 356 grams and included ovary replaced by 11.5 X 9.5 x 7.0 cm solid mass and an unremarkable fallopian tube. The surface of ovarian tumor was tan-pink and smooth, with focal hemorrhagic adhesions. The cut sections revealed solid tan-white and nodular, fleshy tissue, with multiple cystic spaces filled with clear serous fluid (Fig [1](#F1){ref-type="fig"}A). The opposite ovary and fallopian tube were grossly unremarkable.

Microscopically, the right ovarian tumor showed two different patterns. One consisted of rounded cellular pseudolobules embeded in the fibrous stroma (Fig [1](#F1){ref-type="fig"}B), the other of solid sheets or separate small nests of tumor cells with scattered hyaline plaques (Fig [1](#F1){ref-type="fig"}C). The pseudolobules contained mostly small cells with scant cytoplasm and hyperchromatic nuclei, often arranged in cords mimicking single files of metastatic lobular carcinoma (Fig [2](#F2){ref-type="fig"}A). The tumor cells forming solid sheets were larger with hyperchromatic nuclei and clear, vacuolated cytoplasm (Fig [2](#F2){ref-type="fig"}B). In some areas, cytoplasmic vacuoles pushed nuclei to the periphery creating signet-ring pattern (Fig [2](#F2){ref-type="fig"}C). The mitotic activity was 0 per 10 high power fields. Numerous thick-walled blood vessels and areas of cystic degeneration and edema were present throughout the tumor. No definite diagnosis was made on an intraoperative consultation. Although the low power architecture favored stromal tumor, the high power features especially cytologic atypia, clear cell and signet-ring differentiation were suggestive of primary or metastatic carcinoma. The results of the immunostains included: positive nuclear and cytoplasmic staining for calretinin (Fig [3](#F3){ref-type="fig"}A), positive membranous and cytoplasmic staining for vimentin, positive nuclear staining for WT (Fig [3](#F3){ref-type="fig"}C) and focally positive cytoplasmic staining for inhibin 1. The immunostains for CD99, epithelial markers (AE1/AE3, CK 7 and CK 20), estrogen receptor (ER), progesterone receptor (PR), mammaglobin, chromogranin, and S100 protein were negative. Based on the history of radiation treatment and immunohistochemical profile, a diagnosis of ovarian stromal tumor with features of fibrothecoma and sclerosing stromal tumor and superimposed radiation effect was made. The opposite ovary showed changes consistent with status post radiation treatment including stromal fibrosis, prominent thick walled blood vessels and foci of foamy histiocytes, and hemosiderin-laden macrophages.

Discussion
==========

Radiation treatment damages DNA of tumor cells and surrounding normal tissues. The damage is either a direct result of radiation or is due to exposure to free radicals produced by the interaction of radiation and water within the cell. Typical morphologic changes in tissues subjected to radiation affect both, the epithelium and the stroma [@B1]-[@B3]. The nuclei of epithelial cells become enlarged, pleomorphic and hyperchromatic and show irregular chromatin clumping. The cytoplasm develops granular, vacuolated, or clear appearance due to the dilatation and damage of cytoplasmic organelles associated with the destruction of lysosomes. The stromal changes include enlargements of fibroblasts and prominent hyalinization and thickening of blood vessels. The radiosensitivity of individual cells depends on their mitotic index. Therefore, the neoplastic cells are more radiosensitive than cells of normal tissues. As a result, radiation-related changes alter the appearance of normal tissues as well as benign and malignant tumors and therefore may create diagnostic difficulties. Since the surgery remains the primary treatment for ovarian carcinoma, there are only a few reports describing the effects of radiation and chemotherapy treatment on histology of ovarian tumors [@B2],[@B3],[@B6],[@B7]. McCluggage et al. reported morphologic alterations in ovarian serous and endometrioid carcinomas initially treated with chemotherapy [@B6]. As in radiation treatment, the changes affected nuclei and cytoplasm of tumor cells and the surrounding stroma. There was nuclear enlargement, irregularity, hyperchromasia, smudging and irregular chromatin clumping. The cytoplasm was either vacuolated, foamy or deeply eosinophilic. There was also prominent stromal fibrosis associated with inflammation, fat necrosis, foamy histiocytes, cholesterol clefts and hemosiderin laden macrophages. It was noted that morphologic alterations made tumor grading and typing very difficult. A similar observation was published recently by Chew et al., who described histologic changes in ovarian serous carcinoma treated with chemotherapy [@B7]. As a result of the treatment, part of the tumor developed "clear cell differentiation." The distinction from a true clear cell carcinoma was based on the results of immunostains.

Our case illustrates how radiation treatment may change the appearance of benign ovarian stromal tumor and create a diagnostic dilemma, especially during the intraoperative examination. The cytoplasmic vacuolization, nuclear enlargement and hyperchromatism resulting from the radiation may suggest a clear cell differentiation. The prominent stromal fibrosis dividing tumor cells into cords and small nests may create a pattern mimicking single file arrangements of metastatic lobular carcinoma. Finally, the signet-ring differentiation may raise a possibility Krukenberg tumor.

Both, our report and the previous studies indicate that iatrogenic changes should always be taken into consideration when an ovarian tumor shows confusing and unusual features. Radiation and chemotherapy can alter the original histology and make the distinction between different histologic types of ovarian tumors very difficult. As it is evident in our case, sex cord stromal tumors after radiation treatment may develop cellular alterations suggestive of a carcinoma. In conclusion, it is important to recognize radiation and chemotherapy changes, to obtain past clinical history, and resort to immunohistochemical stains when necessary.
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![A. Positive nuclear and cytoplasmic staining for calretinin (original magnification, 40 x). B. Positive cytoplasmic staining for vimentin (original magnification 40 x). C. Positive nuclear staining for WT1 (original magnification 40 x).](jcav02p0228g03){#F3}
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